Cargando…
Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic
The risk/benefit ratio of a number of palliative and (neo)adjuvant treatments should be reconsidered during the COVID-19 pandemic. We provide treatment advice as a pragmatic perspective on the risk/benefit ratio in specific clinical scenarios.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association of Urology. Published by Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164868/ https://www.ncbi.nlm.nih.gov/pubmed/32312544 http://dx.doi.org/10.1016/j.eururo.2020.03.026 |